CFM
MDXG icon

Catalyst Funds Management’s MiMedx Group MDXG Stock Holding History

Catalyst Funds Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,600
Closed -$263K – 610
2025
Q1 		$263K Buy
+34,600
New +$289K 0.07% 290

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Catalyst Funds Management's MDXG Position: Q2 2025 in Review

Catalyst Funds Management sold out of MiMedx Group (MDXG) in Q2 2025, closing a stake of 34,600 shares — an estimated $263K sold.

Catalyst Funds Management first reported a position in MDXG in Q1 2025 and held it in 1 quarter. The position peaked at $263K in Q1 2025. 223 funds tracked by Wall St. Rank hold MDXG as of Q2 2025.

  • Catalyst Funds Management reported no remaining MiMedx Group position as of Q2 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 34,600 MiMedx Group shares in Q2 2025, an estimated $263K.
  • Catalyst Funds Management first reported a position in MiMedx Group in Q1 2025 and held it in 1 quarter.
  • Catalyst Funds Management's MiMedx Group position peaked at $263K in Q1 2025.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2025.

Based on Catalyst Funds Management's 13F filing for Q2 2025, filed 12 Aug 2025.